OBIO® supports the commercialization of early-stage and venture backed companies enabling them to raise capital, build the workforce and accelerate adoption. Through the OBIO® membership, we offer companies and their teams access to mentorship & expert resources, grants and experiential learning opportunities.
WE SUPPORT COMPANIES WITH:
Commercialization
HealthMINT™: increases the preparedness of health science companies for accessing non-dilutive grants, dilutive investments and strategic partnership opportunities.
Capital Access Advisory Program (CAAP®): focuses on accelerating technology commercialization, post-seed financing and strategic partnerships.
OBIO® Investment Summit, Early Technology Showcase and Business Development Forum: drive investment in high potential Canadian health science companies by bringing them together with premier investors from across the globe.
Skills Development & Training
Business development: masterclasses on licensing, entrepreneurship bootcamps, workshops on intellectual property, project management, finance, regulatory pathways, and cross-border tax strategy.
Health to Business Bridge (H2BB™): prepares early career professionals for business and technical early career roles.
OBIO® Job Board and Talent Network™: connects Canadian companies with highly skilled talent in health science.
Health Science Technology Training program: provides digital technology development upskilling to professionals who are ready to transition into high-demand roles in health science and connects them with employers in the sector.
Market Adoption
Early Adopter Health Network (EAHN™): promotes Canadian companies with technologies ready for adoption to a network of health organizations, supporting the organizations to evaluate and disseminate the technologies domestically, which leads to international export.
WE HAVE SPECIAL AREAS OF FOCUS IN:
Women in Health
Women in Health Initiative (WiHI): supports women entering and advancing their careers in business development roles in the health science industry. Among other initiatives, the WiHI Seed Program addresses the significant barriers that women-led health science companies face in accessing financing.
Critical Technologies
Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence: provides infrastructure, commercialization, technology adoption and talent programming to accelerate the use of critical technologies: 5G and advanced networks, ethical artificial intelligence, blockchain, cybersecurity, quantum and robotics